Caplight Directory>Companies>CROSSPOINT Therapeutics-preview>Crosspointrx


CROSSPOINT Therapeutics

CROSSPOINT Therapeutics

Private
South KoreaHealthcare & Life Scienceshttps://www.crosspointrx.com/

Last Round

VC Round

Mar 27, 2026

Total Funding Raised

$1.55M

Company Overview

CROSSPOINT Therapeutics is a biotechnology company that develops a next-generation antibody structure platform called "Stealth-Body" to reduce toxicity in antibody therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

antibody-drug conjugatesADCFc silencingdrug delivery platformantibody engineeringsilent antibodyimmuno-oncologyantibody therapyoff-target toxicitydrug delivery vehicleinert Fc regionbiopharmaceutical partnershipsgene deliveryprotein delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CROSSPOINT Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CROSSPOINT Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 27, 2026
SeedApr 1, 2024
View all Funding Rounds

Key People

Founding team and executive leadership

Ki Hwan C.

Chief Technology Officer

Executive Team

CROSSPOINT Therapeutics Investors

Notable investors and investment history

InvestorRounds
Kite Entrepreneurship FoundationSeed
Korea University HoldingsSeed
Infobank CorpSeed
Bigbang Angels, Inc.Seed
Korea Omega Investment CorpSeed
Kudos VenturesVC Round
View all Investors

CROSSPOINT Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CROSSPOINT Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CROSSPOINT Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth Korea
Employee Range7
Year Founded2022
Last FundingMar 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.